Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Research and Innovation Action · Running

PATHFINDER Point-of-care Lab-on-Chip Detection of Host Response in Febrile Illness for Diagnosis and Etiology Research

Coordinator
Imperial College of Science Technology and Medicine, United Kingdom
Runs
1 October 2026 to 31 March 2030
Status
Running
EU funding
€2.8m
Total cost
€3.2m
Partners
6 organisations in 4 countries
Type
Research and Innovation Action
Grant agreement
101248850

What the project is doing

In the project's own words, from its summary on CORDIS.

Diagnostics are the biggest gap in the cascade of care for priority infectious diseases in sub-Saharan Africa (SSA). Lack of accessible and affordable diagnostics contributes to poor health outcomes, drives antimicrobial resistance, and impedes timely responses to emerging epidemics. The transformative potential of point-of-care molecular host response diagnostics has been recognised but until now, none have been developed specifically for the needs of SSA.

We have developed a lab-on-chip platform to detect malaria, bacterial, viral, and TB infections (and co-infections) based on differences in their host gene-expression response. In this project we will take this platform beyond proof-of-concept, evaluating it in relevant clinical settings to determine the cause of febrile illness in 1000 children in Burkina Faso and Ghana. Through engagement of stakeholders across the translational pathway, we will also assess and optimise usability, impact on care pathways and public health, regulatory approval processes, local manufacturing, and sustainable funding and access models.

In parallel we will build capacity in diagnostics research and innovation and train a cohort of future leaders in the field. This PATHFINDER project will provide evidence for a disruptive approach, with potential to transform the diagnostic ecosystem, and have wide-reaching impact on healthcare delivery in SSA.

Who is involved

OrganisationCityCountryRole
Imperial College of Science Technology and MedicineLondonUnited KingdomCoordinator
Centre National De Recherche Scientifique Et Technologique*institut De Recherche En Sciences De La SanteOuagadougouBurkina FasoParticipant
University of GhanaAccraGhanaParticipant
Stichting Amsterdam UmcAmsterdamNetherlandsParticipant
London School of Hygiene and Tropical Medicine Royal CharterLondonUnited KingdomParticipant
ProtonDx LtdLondonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI